Your browser doesn't support javascript.
loading
Proliferation and interleukin 5 production by CD8hi CD57+ T cells.
Chong, Lee K; Aicheler, Rebecca J; Llewellyn-Lacey, Sian; Tomasec, Peter; Brennan, Paul; Wang, Eddie C Y.
Afiliação
  • Chong LK; Department of Medical Biochemistry & Immunology, School of Medicine, Cardiff University, Cardiff, UK.
Eur J Immunol ; 38(4): 995-1000, 2008 Apr.
Article em En | MEDLINE | ID: mdl-18383036
CD8hi CD57+ T cells have previously been described as effector memory T cells with minimal expansion capacity and high susceptibility to activation-induced cell death. In contrast, we demonstrate here that CD8hi CD57+ T cells are capable of rapid expansion using multiple techniques including [(3)H]thymidine uptake, flow cytometric bead-based enumeration and standard haemocytometer counting. Previous reports can be explained by marked inhibition of activation-induced expansion and increased 7-amino-actinomycin D uptake by CD8hi CD57+ T cells following treatment with CFSE, a dye previously used to measure their proliferation, combined with specific media requirements for the growth of this cell subset. The ability of CD8hi CD57+ T cells to further differentiate is highlighted by a distinct cytokine profile late after activation that includes the unexpected release of high levels of interleukin 5. These data indicate that CD8hi CD57+ T cells should not be considered as "end-stage" effector T cells incapable of proliferation, but represent a highly differentiated subset capable of rapid division and exhibiting novel functions separate from their previously described cytotoxic and IFN-gamma responses.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-5 / Antígenos CD8 / Linfócitos T CD8-Positivos / Antígenos CD57 Limite: Adult / Humans / Middle aged Idioma: En Revista: Eur J Immunol Ano de publicação: 2008 Tipo de documento: Article País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-5 / Antígenos CD8 / Linfócitos T CD8-Positivos / Antígenos CD57 Limite: Adult / Humans / Middle aged Idioma: En Revista: Eur J Immunol Ano de publicação: 2008 Tipo de documento: Article País de publicação: Alemanha